This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A New Treatment for Phenylketonuria

Helen K. Berry, MA; Robert L. Brunner, PhD; Melanie M. Hunt, MEd, RD; Pamela P. White, MSN, RN

Am J Dis Child. 1990;144(5):539-543.

Abstract
• Early treatment of phenylketonuria by dietary phenylalanine restriction prevents brain damage. Behavioral and cognitive deficits occur when serum phenylalanine levels increase. Administration of valine, isoleucine, and leucine to patients with phenylketonuria may inhibit entry of phenylalanine into the brain and reduce its toxic effects on the central nervous system. Sixteen adolescents and young adults with phenylketonuria participated in double-blind trials in which a valine, isoleucine, and leucine mixture or a control mixture was given for four 3-month periods. Biochemical and neuropsychologic tests were carried out before and at the end of each period. Time to completion of a test that required substantial attention with mental processing (Attention Diagnostic Method) was faster during the valine, isoleucine, and leucine periods than during the control mixture periods. Improvement with valine, isoleucine, and leucine on a less demanding task (Continuous Performance Test) approached significance. These data lent support to the hypothesis that a regimen of valine, isoleucine, and leucine may help individuals unable to maintain low serum phenylalanine levels.

(AJDC. 1990;144:539-543)

Author Affiliations
From the Metabolic Disease Center, Children's Hospital Medical Center and the University of Cincinnati (Ohio) College of Medicine.

Footnotes
Accepted for publication November 13, 1989.

Reprint requests to Metabolic Disease Center, Children's Hospital Medical Center, Cincinnati, OH 45229 (Ms Berry).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Branched-Chain Amino Acids and Brain Function
Fernstrom
J. Nutr. 2005;135:1539S-1546S.
ABSTRACT | FULL TEXT  

Future Role of Large Neutral Amino Acids in Transport of Phenylalanine Into the Brain
Matalon et al.
Pediatrics 2003;112:1570-1574.
ABSTRACT | FULL TEXT  

Benefits of Mutation Analysis and Examination of Brain Phenylalanine Levels in the Management of Phenylketonuria
Koch and Güttler
Pediatrics 2000;106:1136-1136.
FULL TEXT  

Neuropsychological and Neuroradiological (MRI) Variations During Phenylalanine Load: Protective Effect of Valine, Leucine, and Isoleucine Supplementation
Leuzzi et al.
J Child Neurol 1997;12:338-340.